Cargando…

In vitro modeling of COPD inflammation and limitation of p38 inhibitor – SB203580

BACKGROUND: Systemic inflammation and steroid resistance are the hallmarks of COPD. We examined the impact of p38 inhibitor (SB203580) in in vitro assays of systemic inflammation using pulmonary cells and patients’ sera. OBJECTIVE AND METHODS: Data from 66 COPD patients and 15 age-/sex-matched healt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Aihong, Zhang, Xiaopeng, Wu, Siyu, Wu, Mingxia, Li, Jing, Yan, Xixin, Kopec-Harding, Kamilla, Wu, Jiakai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2016
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4857829/ https://www.ncbi.nlm.nih.gov/pubmed/27199554 http://dx.doi.org/10.2147/COPD.S99810

Ejemplares similares

The p38 MAPK inhibitor SB203580 differentially modulates LPS-induced interleukin 6 expression in macrophages
por: Shi, Qinghai, et al.
Publicado: (2015)

SB203580—A Potent p38 MAPK Inhibitor Reduces the Profibrotic Bronchial Fibroblasts Transition Associated with Asthma
por: Paw, Milena, et al.
Publicado: (2021)

The p38 MAPK Inhibitor SB203580 Abrogates Tumor Necrosis Factor-Induced Proliferative Expansion of Mouse CD4(+)Foxp3(+) Regulatory T Cells
por: He, Tianzhen, et al.
Publicado: (2018)

A Single Amino Acid Substitution Makes WNK4 Susceptible to SB 203580 and SB 202190
por: Glover, Mark, et al.
Publicado: (2010)

Peripheral Injection of SB203580 Inhibits the Inflammatory-Dependent Synthesis of Proinflammatory Cytokines in the Hypothalamus
por: Herman, Andrzej P., et al.
Publicado: (2014)

Screening of differentially expressed protein kinases in bone marrow endothelial cells and the protective effects of the p38a inhibitor SB203580 on bone marrow in liver fibrosis
por: Gao, Bo, et al.
Publicado: (2016)

Combination of metformin and p38 MAPK inhibitor, SB203580, reduced myocardial ischemia/reperfusion injury in non-obese type 2 diabetic Goto-Kakizaki rats
por: Sanit, Jantira, et al.
Publicado: (2019)

SB203580 Modulates p38 MAPK Signaling and Dengue Virus-Induced Liver Injury by Reducing MAPKAPK2, HSP27, and ATF2 Phosphorylation
por: Sreekanth, Gopinathan Pillai, et al.
Publicado: (2016)

Pharmacological Inhibition of p38 MAPK by SB203580 Increases Resistance to Carboplatin in A2780cp Cells and Promotes Growth in Primary Ovarian Cancer Cells
por: Han, Xiaolu, et al.
Publicado: (2018)

Chronic treatment with TNF-α, alone and in combination with Takinib, SB203580 and metformin induce cell death in breast cancer
por: Abdolvand, Maryam, et al.
Publicado: (2023)

SB203580 increases G-CSF production via a stem-loop destabilizing element in the 3’ untranslated region in macrophages independently of its effect on p38 MAPK activity
por: Chang, Shwu-Fen, et al.
Publicado: (2016)

SB203580, a p38MAPK inhibitor, attenuates olfactory dysfunction by inhibiting OSN apoptosis in AR mice (activation and involvement of the p38 mitogen‐activated protein kinase in olfactory sensory neuronal apoptosis of OVA‐induced allergic rhinitis)
por: Gao, Xian, et al.
Publicado: (2019)

Mid-wavelength infrared avalanche photodetector with AlAsSb/GaSb superlattice
por: Li, Jiakai, et al.
Publicado: (2021)

Role of p38 MAPK and STAT3 in lipopolysaccharide-stimulated mouse alveolar macrophages
por: MENG, AIHONG, et al.
Publicado: (2014)

High serum macrophage inflammatory protein-3α is associated with the early recurrence or metastasis of non-small cell lung cancer following primary pulmonary resection
por: ZHANG, XIAOPENG, et al.
Publicado: (2014)

A stress response p38 MAP kinase inhibitor SB202190 promoted TFEB/TFE3-dependent autophagy and lysosomal biogenesis independent of p38
por: Yang, Chuanbin, et al.
Publicado: (2020)

On the decay of 110Sb, 111Sb, 112Sb, 113Sb and 114Sb
por: Sunier, J W, et al.
Publicado: (1970)

Safety and efficacy of p38 mitogen-activated protein kinase inhibitors (MAPKIs) in COPD
por: Yu, Haichuan, et al.
Publicado: (2022)

Flexible SbSI/Polyurethane Nanocomposite for Sensing and Energy Harvesting
por: Nowacki, Bartłomiej, et al.
Publicado: (2022)

Rh–Sb Nanoclusters: Synthesis, Structure, and Electrochemical Studies of the Atomically Precise [Rh(20)Sb(3)(CO)(36)](3–) and [Rh(21)Sb(2)(CO)(38)](5–) Carbonyl Compounds
por: Femoni, Cristina, et al.
Publicado: (2020)

Activity of sputum p38 MAPK is correlated with airway inflammation and reduced FEV(1) in COPD patients
por: Huang, Cuiping, et al.
Publicado: (2013)

Two sb or not two sb?
por: Kado, M, et al.
Publicado: (2000)

Dataset on the microstructure Ni(50)Mn(38)Sb(9)Si(3) alloy and compositions of Ni(50)Mn(38)Sb(12−x)Si(x) (x=2.5, 3) ferromagnetic shape memory alloys
por: Zhang, Ruochen, et al.
Publicado: (2018)

The oral HDAC inhibitor pracinostat (SB939) is efficacious and synergistic with the JAK2 inhibitor pacritinib (SB1518) in preclinical models of AML
por: Novotny-Diermayr, V, et al.
Publicado: (2012)

Protective Effects of p38 MAPK Inhibitor SB202190 against Hippocampal Apoptosis and Spatial Learning and Memory Deficits in a Rat Model of Vascular Dementia
por: Yang, Shen, et al.
Publicado: (2013)

Differential anti-inflammatory effects of budesonide and a p38 MAPK inhibitor AZD7624 on COPD pulmonary cells
por: Higham, Andrew, et al.
Publicado: (2018)

LABAs and p38MAPK Inhibitors Reverse the Corticosteroid-Insensitivity of IL-8 in Airway Smooth Muscle Cells of COPD
por: Knobloch, Jürgen, et al.
Publicado: (2019)

Effect of the inhaled PDE4 inhibitor CHF6001 on biomarkers of inflammation in COPD
por: Singh, Dave, et al.
Publicado: (2019)

Two additive mechanisms impair the differentiation of 'substrate-selective' p38 inhibitors from classical p38 inhibitors in vitro
por: Hendriks, Bart S, et al.
Publicado: (2010)

Effect of Erdosteine on COPD Exacerbations in COPD Patients with Moderate Airflow Limitation
por: Calverley, Peter MA, et al.
Publicado: (2019)

Body composition and functional limitation in COPD
por: Eisner, Mark D, et al.
Publicado: (2007)

Limitation of COPD Studies in Animal Modeling
por: Mortaz, Esmaeil, et al.
Publicado: (2012)

Combination therapy for airflow limitation in COPD
por: Ghanei, Mostafa, et al.
Publicado: (2012)

Sorghum Phytochrome B Inhibits Flowering in Long Days by Activating Expression of SbPRR37 and SbGHD7, Repressors of SbEHD1, SbCN8 and SbCN12
por: Yang, Shanshan, et al.
Publicado: (2014)

Differential Effects of p38, MAPK, PI3K or Rho Kinase Inhibitors on Bacterial Phagocytosis and Efferocytosis by Macrophages in COPD
por: Bewley, Martin A., et al.
Publicado: (2016)

Smooth termination of intruder bands in $^{109}$Sb and $^{51}$Sb
por: Schnare, H, et al.
Publicado: (1996)

Synthesis and Crystal Structure of the Zintl Phases NaSrSb, NaBaSb and NaEuSb
por: Wang, Yi, et al.
Publicado: (2023)

Enhanced thermoelectric properties of Zn-doped GaSb nanocomposites
por: Fu, Qiang, et al.
Publicado: (2020)

In Vitro Effects of SB202190 on Echinococcus granulosus
por: Lv, Hailong, et al.
Publicado: (2013)

COPD assessment test and severity of airflow limitation in patients with asthma, COPD, and asthma–COPD overlap syndrome
por: Kurashima, Kazuyoshi, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_f9ddqi9oqiu936p50mjeug6pte